Coloplast A/S Sponsored ADR (CLPBY)
(Delayed Data from OTC)
$12.15 USD
+0.01 (0.08%)
Updated Jun 7, 2024 03:59 PM ET
4-Sell of 5 4
C Value C Growth C Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CLPBY 12.15 +0.01(0.08%)
Will CLPBY be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for CLPBY based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for CLPBY
Coloplast A/S's Dividend Analysis
Coloplast A/S goes ex-dividend tomorrow
Coloplast A/S 2024 Q2 - Results - Earnings Call Presentation
Coloplast A/S (CLPBF) Q2 2023/2024 Earnings Call Transcript
Coloplast price target lowered by DKK 5 at Barclays